As of 2025-03-24, the Relative Valuation of Novacyt SA (ALNOV.PA) is (15.88) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.55 EUR, the upside of Novacyt SA based on Relative Valuation is -3003.5%.
The range of the Relative Valuation is (17.00) - (16.55) EUR.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | 31.9x - 33.2x | 31.9x |
| Forward P/E multiples | 26.0x - 31.1x | 27.7x |
| Fair Price | (17.00) - (16.55) | (15.88) |
| Upside | -3208.1% - -3126.3% | -3003.5% |
| Date | P/E |